404
Transcatheter Mitral Valve Replacement (TMVR) Market Report
Global Transcatheter Mitral Valve Replacement (TMVR) Market, Dynamics, and Market Analysis
The report on the Global Transcatheter Mitral Valve Replacement (TMVR) Market is segmented by Type (MitraClip, Edwards PASCAL, Edwards SAPIEN 3), Application (Functional Mitral Regurgitation (FMR), Degenerative Mitral Regurgitation (DMR)), and Region...
The transcatheter mitral valve replacement market is expected to witness an impressive growth of 26.0% CAGR in the foreseeable future.
Abbott Laboratories (The U.S), Micro Interventional Devices, Inc. (The U.S), Edward Lifecsiences Incorporation (The U.S), Neovasc Inc. (Canada), Medtronic plc (The U.S), Biotronik (Germany), Colibri Heart Valve LLC (The U.S), LivaNova, PLC (UK), NeoChord, Inc. (The U.S) and Coramaze technologies GmbH (Germany) are among the key players in the transcatheter mitral valve replacement market.
The transcatheter mitral valve replacement market size is expected to reach USD 3,437.5 million in the coming years.
North America accounted for the largest share of transcatheter mitral valve replacement market in 2020.
The functional mitral regurgitation segment accounted for the largest share of the transcatheter mitral valve replacement market in 2020.
Increasing number of people particularly the geriatric population suffering from cardiovascular diseases, growing emphasis on developing technologically advanced solutions in surgical procedures, increasing demand for minimally invasive procedures over open-heart surgeries are the factors driving the growth of transcatheter mitral valve replacement market.
Transcatheter mitral valve replacement (TMVR) manufacturers, Transcatheter mitral valve replacement (TMVR) suppliers, Transcatheter mitral valve replacement (TMVR) distributors, Organizations, Government bodies are the target audience in the transcatheter mitral valve replacement market.